[1] Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress—A concise review. Saudi Pharm J 2016;24:547–553.
[2] Federation ID. IDF diabetes atlas eighth edition. 2017.
[3] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018;14:88.
[4] Maritim AC, Sanders aRA, Watkins Iii JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24–38.
[5] Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405–412.
[6] Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000;49:27–29.
[7] Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89.
[8] Arora R, Vig AP, Arora S. Lipid peroxidation: a possible marker for diabetes. J Diabetes Metab S 2013;11:1–6.
[9] Wu JQ, Kosten TR, Zhang XY. Free radicals, antioxidant defense systems, and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013;46:200–206.
[10] Shah AA, Sinha AA. Oxidative stress and autoimmune skin disease. Eur J Dermatol 2013;23:5–13.
[11] Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet Br Ed 1994;344:721–724.
[12] Mahboob M, Rahman MF, Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J 2005;46:322.
[13] Mallick AK, Maradi R, Joshi VR, Shorey G, Ahsan M. A study on malondialdehyde as a marker of lipid peroxidation in male and female patients with type 2 diabetes mellitus 2011;8(2):198-201.
[14] Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993;214:227–234.
[15] Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant Status and Lipid Peroxidation in Type II Diabetes Mellitus with and without Complications. Clin Sci 1996;90:255–60. https://doi.org/10.1042/cs0900255.
[16] Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002;251:69–76. https://doi.org/10.1046/j.1365-2796.2002.00927.x.
[17] Duman BS, Öztürk M, Yilmazer S, Hatemi H. Thiols, malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus. Tohoku J Exp Med 2003;201:147–155.
[18] Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003;21:291–6. https://doi.org/10.1002/cbf.1025.
[19] Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003;36:557–62. https://doi.org/10.1016/S0009-9120(03)00094-8.
[20] Atli T, Keven K, Avci A, Kutlay S, Turkcapar N, Varli M, et al. Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients. Arch Gerontol Geriatr 2004;39:269–75. https://doi.org/10.1016/j.archger.2004.04.065.
[21] Gupta M, Chari S. Proxidant and antioxidant status in patients of type II Diabetes Mellitus with IHD. Indian J Clin Biochem 2006;21:118–22. https://doi.org/10.1007/BF02912925.
[22] Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci 2007;112:599–606. https://doi.org/10.1042/CS20060323.
[23] Tangvarasittichai S. Serum Levels of Malondialdehyde in Type 2 Diabetes Mellitus Thai Subjects 2009;61:5.
[24] Kamal M, Salem M, Kholousi N, Ashmawy K. Evaluation of trace elements and Malondialdehyde levels in type II diabetes mellitus. Diabetes Metab Syndr Clin Res Rev 2009;3:214–8. https://doi.org/10.1016/j.dsx.2009.07.007.
[25] Salem M, Kholoussi S, Kholoussi N, Fawzy R. Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus. Arch Hell Med 2011;28:83–8.
[26] Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 2011;8:22–8. https://doi.org/10.1177/1479164110390243.
[27] Khemka VK, Choudhuri S, Ganguly A, Ghosh A, Bir A, Banerjee A. Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus. Adv Endocrinol 2014;2014:1–6. https://doi.org/10.1155/2014/830761.
[28] M. Kusuma Kumari, T. Sankaranarayana. Evaluation of Oxidative Stress in Type 2 Diabetes Mellitus Patients. IOSR J Dent Med Sci 2014;13:46–50. https://doi.org/10.9790/0853-13534650.
[29] Rani AJ. Study on Total Antioxidant Status in Relation to Oxidative Stress in Type 2 Diabetes Mellitus. J Clin Diagn Res 2014. https://doi.org/10.7860/JCDR/2014/7603.4121.
[30] Shang M, Zhao J, Yang L, Lin L. Oxidative stress and antioxidant status in women with gestational diabetes mellitus diagnosed by IADPSG criteria. Diabetes Res Clin Pract 2015;109:404–10. https://doi.org/10.1016/j.diabres.2015.05.010.
[31] Kulaksızoglu S, Karalezli A. Aqueous humour and serum levels of nitric oxide, malondialdehyde and total antioxidant status in patients with type 2 diabetes with proliferative diabetic retinopathy and nondiabetic senile cataracts. Can J Diabetes 2016;40:115–119.
[32] Mishra S, Mishra B. Study of lipid peroxidation, nitric oxide end product, and trace element status in type 2 diabetes mellitus with and without complications. Int J Appl Basic Med Res 2017;7:88. https://doi.org/10.4103/2229-516X.205813.
[33] Banik S, Hossain MS, Bhatta R, Akter M. Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin. J Res Med Sci 2018;23:77.
[34] Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications 2001;15:203–210.
[35] Fleming PS, Koletsi D, Pandis N. Blinded by PRISMA: are systematic reviewers focusing on PRISMA and ignoring other guidelines? PLoS One 2014;9:e96407.
[36] Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
[37] Brownlee M. Negative consequences of glycation. Metabolism 2000;49:9–13.
[38] Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339–352.
[39] Das A, Sarwar MS, Hossain MS, Karmakar P, Islam MS, Hussain ME, et al. Elevated serum lipid peroxidation and reduced vitamin C and trace element concentrations are correlated with Epilepsy. Clin EEG Neurosci 2019;50:63–72.
[40] Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of oxidative stress during diabetes mellitus. J Biomark 2013;2013.
[41] Livingstone C, Davis J. Targeting therapeutics against glutathione depletion in diabetes and its complications. Br J Diabetes Vasc Dis 2007;7:258–265.
[42] MEMİŞOĞULLARI R, Tuerkeli M, Bakan E, Akcay F. Effect of Metformin or Gliclazide on lipid peroxidation and antioxidant levels in patients with diabetes mellitus. Turk J Med Sci 2008;38:545–548.
[43] Sekhar RV, McKay SV, Patel SG, Guthikonda AP, Reddy VT, Balasubramanyam A, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011;34:162–167.